Study Reveals Persistent Diversity Gaps in US Antidepressant Trials

A new study published in The Journal of Clinical Psychiatry highlights persistent reporting gaps and underrepresentation of multiple minority racial/ethnic groups in US antidepressant trials. The research found underrepresentation of Asian, American Indian/Alaska Native, multiracial, and Hispanic/Latino participants, limiting the generalizability of trial findings. The authors emphasize the need for clearer reporting standards and targeted recruitment strategies to address these disparities.